Sign In
Buy FLGT
$16.55
-3.66 (-18.11%)
At Close: Jul 31, 2026
Moffitt Cancer Center and Fulgent Pharma Join Forces to Revolutionize Cancer Therapeutics
04:05pm, Tuesday, 14'th May 2024
TAMPA, Fla. & LOS ANGELES--(BUSINESS WIRE)--Moffitt Cancer Center, a world-renowned cancer treatment and research center, and Fulgent Pharma, a subsidiary of Fulgent Genetics, Inc. (NASDAQ: FLGT) and
Fulgent Genetics, Inc. (FLGT) Reports Q1 Loss, Misses Revenue Estimates
09:16am, Friday, 03'rd May 2024
Fulgent Genetics, Inc. (FLGT) came out with a quarterly loss of $0.01 per share versus the Zacks Consensus Estimate of a loss of $0.33. This compares to loss of $0.22 per share a year ago.
Fulgent Reports First Quarter 2024 Financial Results
07:00am, Friday, 03'rd May 2024
EL MONTE, Calif.--(BUSINESS WIRE)--Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent,” or the “Company”), a technology-based company with a well-established laboratory services business and a th
Fulgent Genetics to Announce First Quarter 2024 Financial Results on Friday, May 3, 2024
04:05pm, Thursday, 11'th Apr 2024
EL MONTE, Calif.--(BUSINESS WIRE)--Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent” or the “Company”), a technology-based company with a well-established laboratory services business and a the
Fulgent Genetics (FLGT) Q4 2023 Earnings Call Transcript
10:59am, Wednesday, 28'th Feb 2024
Fulgent Genetics (FLGT) Q4 2023 Earnings Call Transcript
Fulgent Reports Fourth Quarter and Full Year 2023 Financial Results
07:00am, Wednesday, 28'th Feb 2024
EL MONTE, Calif.--(BUSINESS WIRE)--Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent,” or the “Company”), a technology-based company with a well-established laboratory services business and a th
Fulgent Genetics: Buy Growth Ahead Below Liquidation Value
07:20am, Wednesday, 21'st Feb 2024
Fulgent Genetics spent the past 2 years digesting the Covid cliff, which wiped out 80% of its market capitalization since the 2021 peak. The company is about to hit an inflection point, as 2024 will b
Cord Blood Registry® (CBR®) by CooperSurgical® and Fulgent Genetics Launch Innovative Genetic Testing
08:31am, Friday, 09'th Feb 2024
Testing offers CBR families the opportunity to proactively seek additional information about their child's health TRUMBULL, Conn. and EL MONTE, Calif.
The 3 Best Digital Health Stocks for Personalized Medicine
09:45am, Saturday, 25'th Nov 2023
If you're searching for digital health stocks to add to your portfolio, look no further. Technological innovation is leading to the increased digitalization and personalization of healthcare.
Fulgent to Participate in the Piper Sandler 35th Annual Healthcare Conference
04:30pm, Tuesday, 14'th Nov 2023
EL MONTE, Calif.--(BUSINESS WIRE)--Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent” or the “Company”), a technology-based company with a well-established clinical diagnostic business and a the
Fulgent Shares Data from Two Poster Presentations at SITC 2023 Annual Meeting
04:05pm, Friday, 03'rd Nov 2023
EL MONTE, Calif.--(BUSINESS WIRE)--Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent” or the “Company”), a technology-based company with a well-established clinical diagnostic business and a the
Fulgent Genetics, Inc. (FLGT) Q3 2023 Earnings Call Transcript
12:22pm, Friday, 03'rd Nov 2023
Fulgent Genetics, Inc. (NASDAQ:FLGT ) Q3 2023 Earnings Call Transcript November 3, 2023 8:30 AM ET Company Participants Melanie Solomon - IR Ming Hsieh - CEO Brandon Perthuis - CCO Paul Kim - CFO Lawr
Fulgent Genetics, Inc. (FLGT) Reports Q3 Loss, Tops Revenue Estimates
09:47am, Friday, 03'rd Nov 2023
Fulgent Genetics, Inc. (FLGT) came out with a quarterly loss of $0.39 per share versus the Zacks Consensus Estimate of a loss of $0.32. This compares to earnings of $0.32 per share a year ago.
Fulgent Reports Third Quarter 2023 Financial Results
07:00am, Friday, 03'rd Nov 2023
EL MONTE, Calif.--(BUSINESS WIRE)--Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent” or the “Company”), a technology-based company with a well-established clinical diagnostic business and a the
Fulgent Announces Two Poster Presentations at SITC 2023 Annual Meeting
08:00am, Wednesday, 25'th Oct 2023
EL MONTE, Calif.--(BUSINESS WIRE)--Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent” or the “Company”), a technology-based company with a well-established clinical diagnostic business and a the
